Market Capitalization

IUOE Local 150 backs Speaker Welch for State Central Committeeperson, signaling a major power play in Illinois Democratic politics post-Danny Davis.

With battery and solar costs plummeting, a new era of sustainable energy is dawning—driven by profit, not just policy. Here's the roadmap.

A new UC Berkeley-backed study finds Gridware's tech cuts fire ignitions by 48% and reduces outages, proving its economic and safety value.

VPT's new VSCPL1210SG converter combines high efficiency and radiation tolerance, aiming to power the next generation of cost-effective LEO satellites.

Ripple Prime's new integration with top derivatives protocol Hyperliquid provides a capital-efficient, risk-managed gateway for institutional finance into DeFi.

The frozen potato giant appoints an AB InBev veteran as Executive Chair and a new CFO, signaling a major push for global expansion and shareholder value.

Real estate firm Manor Park Ventures opens a new HQ at Switch2 Ten, signaling aggressive growth in multifamily projects and a diversified investment strategy.

As EQB prepares to release its Q1 2026 results, investors are watching to see if its digital strategy and PC Financial deal can fuel a rebound.

The AI boom runs on powerful chips that generate immense heat. Discover how the once-overlooked HVAC industry is now a critical infrastructure investment.

Amid financial scrutiny and following a major trial failure, Vistagen's upcoming Q3 update is a critical test for its novel pherine pipeline.

MetaVia's drug vanoglipel gets a major boost from AI modeling, validating its potential to treat complex metabolic diseases like MASH and Type 2 Diabetes.

A top KLAS award reveals a new era in healthcare cybersecurity, where measurable risk reduction and financial value are becoming more important than ever.

A new study reveals financial firms see big returns from AI but struggle with deployment due to poor data quality and IT complexity, forcing a major rethink.

An expanded partnership aims to deliver a once-daily oral tablet for hypoparathyroidism, potentially revolutionizing treatment for thousands of patients.

Nasdaq-listed Zeta Network Group is exploring real-world asset tokenization, signaling a pivotal move beyond Bitcoin for institutional treasury management.

Affinia Therapeutics gets the green light for a human trial of AFTX-201, a one-time therapy for a devastating genetic heart disease, BAG3 DCM.

After uniting nine acquired firms under one brand, NowVertical is shifting its focus to organic growth, leveraging integrated operations to exceed targets.

In a landmark deal for Canadian fintech, a federally regulated bank will custody QCAD's reserves, paving the way for institutional stablecoin adoption.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

VENU closes a $13M deal for its first indoor venue, bringing an innovative fractional ownership "FireSuite" concept to the Denver area.